This research explores how immune-related cells and molecules, beneficial in wound healing, may become harmful in Parkinson’s disease. Using the fruit fly as a model organism, the study investigates which inflammatory processes contribute to brain damage. Early results suggest that excessive activation worsens degeneration, offering potential targets for future therapies.

This research investigates how melanoma switches between two gene states—one fast-growing and treatable, the other slow but highly invasive and responsible for brain metastases. By identifying genes that control this transition, the study aims to force melanoma into a more treatable form, improving therapeutic options and patient outcomes.

This research investigates how a gonorrhea protein is processed in E. coli using cellular signal sequences, which act like "ZIP codes" directing the protein to its proper location. By identifying effective signal sequences, the study informs potential molecular targets for earlier detection and better treatment, aiming to prevent gonorrhea-related infertility and improve women's reproductive health.

This research investigates β-caryophyllene, a natural compound found in black pepper, as a protective treatment for diabetic kidney disease. The compound shields kidney cells from high-glucose damage, offering a promising, safe, plant-based therapeutic pathway for preventing diabetic nephropathy and improving long-term outcomes for patients.

This research targets cancer more precisely by focusing on a unique region of the PLK1 protein that drives tumor growth. By designing drugs that bind specifically to this domain using AI and laboratory testing, the approach aims to kill cancer cells while sparing healthy tissue.

This talk explains how devastating brain diseases such as Parkinson’s disease and dementia may begin not in the brain, but in the gut. The speaker describes how a protein called alpha-synuclein can change shape, form toxic complexes, and spread from cell to cell, traveling from the gut to the brain via neural connections. Once in the brain, these toxic complexes disrupt movement, memory, and thinking. The research identifies a key protein, FABP2, that promotes this harmful process by interacting with alpha-synuclein. By targeting and breaking this interaction early—at the level of the gut—the work aims to prevent neurodegenerative disease before irreversible brain damage occurs, potentially reducing patient suffering as well as medical and societal costs.

Researchers describe a simple strategy to slow Alzheimer’s disease by capping toxic tau protein chains. Inspired by a ring-stacking toy, they engineered spiky molecular “hats” that bind tau, halt aggregation, and reduce spread in cellular and postmortem brain models, suggesting broad potential across neurodegenerative disorders with future therapeutic promise worldwide.

This research explores how parasitic tapeworms suppress the immune system and how their mechanisms could inspire new treatments for autoimmune diseases. As infections decline, autoimmune conditions rise. Studying rat tapeworm–derived extracellular vesicles, the lab investigates how these molecular signals reprogram inflammatory macrophages, potentially leading to novel therapies that safely regulate immune dysfunction.

This research develops a novel MRI-based method to detect blood–brain barrier leakage associated with stroke. By comparing pre- and post-contrast brain images, the approach enables early detection, monitoring of treatment response, and risk prediction, offering new possibilities for stroke prevention and improved patient outcomes

This research develops a nanoparticle-based diagnostic test for thrombotic thrombocytopenic purpura (TTP), a rare and deadly blood disorder. By enabling fast, affordable detection of the ADAMTS13 enzyme, the system could allow earlier diagnosis, timely treatment, and improved survival while inspiring new approaches to rare disease diagnostics.